Acasti Pharma Inc.
13F holders, Q1 2024 (March 31)10holders
$3.43avg. 13F price*
At the end of Q1 2024, 10 institutions reported holding Acasti Pharma Inc. in their 13F filings. The largest holders were AIGH Capital Management LLC ($1.7M), Bank of America Corp. ($1.7M) and ADAR1 Capital Management, LLC ($745K).
- Company
- Acasti Pharma Inc.
- CUSIP
- 00430K865
- Latest filing quarter
- Q4 2025
History
Number of 13F holders
Total Exit/New Position Q1 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 3 | $1.8M |
| Exits | 2 | $144 |
Ownership 10 holders
| AIGH Capital Management LLC | 0.82% | New | 497,359 | $1.7M |
| Bank of America Corp. | 0.00% | No change | 494,698 | $1.7M |
| ADAR1 Capital Management, LLC | 0.20% | Add +529.5% | 217,381 | $745K |
| Susquehanna International Group, LLP | 0.00% | New | 36,650 | $126K |
| Royal Bank of Canada | 0.00% | Reduce -60.2% | 12,584 | $43K |
| National Bank of Canada | 0.00% | No change | 2,901 | $8K |
| UBS Group AG | 0.00% | Reduce -65.2% | 1,947 | $7K |
| Morgan Stanley | 0.00% | No change | 1,882 | $6K |
| Lanark Financial, Inc. | 0.00% | New | 2 | $1K |
| Federation des caisses Desjardins du Quebec | 0.00% | No change | 28 | $96 |
"% of holder's portfolio" is ACASTI PHARMA INC's weight in each manager's 13F, not the share of Acasti Pharma Inc. the manager owns.